Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer's Disease Model.
Level 5 - mechanism / opinion, no new human data
Preclinical animal model and postmortem tissue study
PubMed 30737131 · doi:10.1016/j.neuron.2019.01.014
What was done
Researchers evaluated the effects of the blood protein fibrinogen on dendritic spine loss and cognitive impairment. The study utilized 3D molecular labeling in cleared mouse and human Alzheimer's disease brain tissue, repetitive in vivo two-photon microscopy, reactive oxygen species inhibition, CD11b genetic ablation, and targeted genetic deletion of the fibrinogen-CD11b binding motif in the 5XFAD transgenic mouse model.
What was found
The abstract reports qualitative findings without numerical data or effect sizes. Focal fibrinogen deposition was associated with dendritic spine loss independent of amyloid plaques. Fibrinogen-mediated spine elimination was prevented by reactive oxygen species inhibition or CD11b knockout. Eliminating the CD11b binding motif on fibrinogen attenuated neuroinflammation, synaptic deficits, and cognitive decline in 5XFAD mice.
Why it matters
The study identifies a mechanism by which cerebrovascular leakage of fibrinogen triggers microglia-driven synaptic pruning and cognitive deficits via CD11b signaling, highlighting an amyloid-independent pathway in neurodegenerative disease.
Limits
The abstract provides no exact sample sizes, numerical values, or statistical precision metrics. Findings are largely derived from transgenic mouse models and postmortem human brain tissue, which may not fully reflect clinical disease progression in living patients.
Cited by
- supports Fibrinogen binds to CD11b receptors on microglia, triggering an inflammatory reaction in the brain.